Oct 28, 2025 | Data Analytics, Industry Trends, Market Scan, New Technology
Examining the innovation-to-risk balance among the pharmaceutical industry’s top companies In our previous post, we evaluated the pharmaceutical industry’s leading companies in terms of overall R&D pipeline strength, resulting in Roche, AstraZeneca, Bristol-Myers...
Oct 26, 2025 | Business, Data Analytics, Industry Trends, Market Scan, New Technology, Probability of Success
The leaders, the contenders, and the strategies for success As we approach the 4th quarter of 2025, let’s review where the pharmaceutical industry’s leading companies rank in terms of overall pipeline strength. Roche, AstraZeneca, and Bristol-Myers Squibb sit in a...
Oct 23, 2025 | Industry Trends, New Technology
We anticipate scientific reviews and clinical trial updates from 40 companies on nearly 80 oncology development programs at the upcoming American Association for Cancer Research (AACR) Annual Meeting, which will take place April 5-10 in San Diego. The information...
Sep 29, 2025 | Industry Trends
The Challenges with Predicting Catalyst Events “Chasing headlines” for catalyst events in the biotech and pharmaceutical markets is a common frustration of investing in these spaces. Predicting these headlines in advance is a primary goal, along with mastering the...
Sep 29, 2025 | Industry Trends, New Technology
The problem with Big Data is that it is so Big! This issue is especially true in the world of healthcare and drug development. It is difficult to see across all the good clinical/scientific work going on around the world and understand exactly where we are headed...
Sep 29, 2025 | Industry Trends
FDA Expedited Drug Development Programs The Food and Drug Administration (FDA) follows an established and lengthy approval process that ensures patients have access to therapeutic agents proven to be safe and effective. The process relies upon a structured framework...
